Ligand regulation of a constitutively dimeric EGF receptor

Nature Communications

Volumn 6, Issue , 2015, Pages

  Freed, Daniel M ^a   Alvarado, Diego ^a,b   Lemmon, Mark A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Kolltan Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN RECEPTOR; LIGAND;

LIGAND; MUTATION; NEMATODE; PROTEIN;

ARTICLE; CAENORHABDITIS ELEGANS; DIMERIZATION; MUTATIONAL ANALYSIS; NONHUMAN; OLIGOMERIZATION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CHEMISTRY; DROSOPHILA MELANOGASTER; METABOLISM;

CAENORHABDITIS ELEGANS;

ANIMALS; CAENORHABDITIS ELEGANS; CELL LINE; DIMERIZATION; DROSOPHILA MELANOGASTER; LIGANDS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84931281794     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8380     Document Type: Article

References (40)

1. Lemmon, M. A. & Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 141, 1117-1134 (2010).
2. Schlessinger, J. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13, 443-447 (1988).
3. Williams, L. T. Signal transduction by the platelet-derived growth factor receptor. Science 243, 1564-1570 (1989).
4. Lu, C. et al. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol. Cell. Biol. 30, 5432-5443 (2010).
5. Mi, L. Z. et al. Simultaneous visualization of the extracellular and cytoplasmic domains of the epidermal growth factor receptor. Nat. Struct. Mol. Biol. 18, 984-989 (2011).
6. Bessman, N. J., Freed, D. M. & Lemmon, M. A. Putting together structures of epidermal growth factor receptors. Curr. Opin. Struct. Biol. 29, 95-101 (2014).
7. Endres, N. F. et al. Conformational coupling across the plasma membrane in activation of the EGF receptor. Cell 152, 543-556 (2013).
8. Maruyama, I. N. Mechanisms of activation of receptor tyrosine kinases: Monomers or dimers. Cells 3, 304-330 (2014).
9. De Meyts, P. The insulin receptor: A prototype for dimeric, allosteric membrane receptors? Trends Biochem. Sci. 33, 376-384 (2008).
10. McKern, N. M. et al. Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature 443, 218-221 (2006).
11. Kavran, J. M. et al. How IGF-1 activates its receptor. eLife 3, e03772 (2014).
12. Menting, J. G. et al. How insulin engages its primary binding site on the insulin receptor. Nature 493, 241-245 (2013).
13. Ward, C. W., Menting, J. G. & Lawrence, M. C. The insulin receptor changes conformation in unforeseen ways on ligand binding: Sharpening the picture of insulin receptor activation. Bioessays 35, 945-954 (2013).
14. Aroian, R. V., Koga, M., Mendel, J. E., Ohshima, Y. & Sternberg, P. W. The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily. Nature 348, 693-699 (1990).
15. Hill, R. J. & Sternberg, P. W. The gene lin-3 encodes an inductive signal for vulval development in C. elegans. Nature 358, 470-476 (1992).
16. Lemmon, M. A. et al. Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J. 16, 281-294 (1997).
17. Alvarado, D., Klein, D. E. & Lemmon, M. A. Structural basis for negative cooperativity in growth factor binding to an EGF receptor. Cell 142, 568-579 (2010).
18. Alvarado, D., Klein, D. E. & Lemmon, M. A. ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor. Nature 461, 287-291 (2009).
19. Schlessinger, J. in Physical Chemistry of Cell Surface Events in Cellular Regulation. (eds De Lisi, C. & Blumenthal, R.) 89-118 (Elsevier, 1979).
20. Red Brewer, M. et al. The juxtamembrane region of the EGF receptor functions as an activation domain. Mol. Cell 34, 641-651 (2009).
21. Jura, N. et al. Mechanism for activation of the EGF receptor catalytic domain by the juxtamembrane segment. Cell 137, 1293-1307 (2009).
22. Mendrola, J. M., Berger, M. B., King, M. C. & Lemmon, M. A. The single transmembrane domains of ErbB receptors self-associate in cell membranes. J. Biol. Chem. 277, 4704-4712 (2002).
23. Grasberger, B., Minton, A. P., DeLisi, C. & Metzger, H. Interaction between proteins localized in membranes. Proc. Natl Acad. Sci. USA 83, 6258-6262 (1986).
24. Macdonald-Obermann, J. L. & Pike, L. J. Different epidermal growth factor (EGF) receptor ligands show distinct kinetics and biased or partial agonism for homodimer and heterodimer formation. J. Biol. Chem. 289, 26178-26188 (2014).
25. Golembo, M., Yarnitzky, T., Volk, T. & Shilo, B. Z. Vein expression is induced by the EGF receptor pathway to provide a positive feedback loop in patterning the Drosophila embryonic ventral ectoderm. Genes Dev. 13, 158-162 (1999).
26. Garrett, T. P. J. et al. Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha. Cell 110, 763-773, 2002).
27. Dawson, J. P., Bu, Z. & Lemmon, M. A. Ligand-induced structural transitions in ErbB receptor extracellular domains. Structure 15, 942-954 (2007).
28. Thiel, K. W. & Carpenter, G. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation. Proc. Natl Acad. Sci. USA 104, 19238-19243 (2007).
29. Yarden, Y. & Sliwkowski, M. X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2, 127-137 (2001).
30. Klein, D. E., Stayrook, S. E., Shi, F., Narayan, K. & Lemmon, M. A. Structural basis for EGFR ligand sequestration by Argos. Nature 453, 1271-1275 (2008).
31. Miura, G. I. et al. Palmitoylation of the EGFR ligand Spitz by Rasp increases Spitz activity by restricting its diffusion. Dev. Cell 10, 167-176 (2006).
32. Ferguson, K. M., Darling, P. J., Mohan, M. J., Macatee, T. L. & Lemmon, M. A. Extracellular domains drive homo-but not hetero-dimerization of erbB receptors. EMBO J. 19, 4632-4643 (2000).
33. Dawson, J. P. et al. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol. Cell. Biol. 25, 7734-7742 (2005).
34. Konarev, P. V., Volkov, V. V., Sokolova, A. V., Koch, M. H. J. & Svergun, D. I. PRIMUS: A Windows PC-based system for small-angle scattering data analysis. J. Appl. Crystallogr. 36, 1277-1282 (2003).
35. Nielsen, S. S. et al. BioXTAS RAW, a software program for high-throughput automated small-angle X-ray scattering data reduction and preliminary analysis. J. Appl. Crystallogr. 42, 959-964 (2009).
36. Semenyuk, A. V. & Svergun, D. I. Gnom-a program package for small-angle scattering data-processing. J. Appl. Crystallogr. 24, 537-540 (1991).
37. Mylonas, E. & Svergun, D. I. Accuracy of molecular mass determination of proteins in solution by small-angle X-ray scattering. J. Appl. Crystallogr. 40, S245-S249 (2007).
38. Svergun, D. I. Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophys. J. 76, 2879-2886 (1999).
39. Volkov, V. V. & Svergun, D. I. Uniqueness of ab-initio shape determination in small-angle scattering. J. Appl. Crystallogr. 36, 860-864 (2003).
40. Klein, D. E., Nappi, V. M., Reeves, G. T., Shvartsman, S. Y. & Lemmon, M. A. Argos inhibits epidermal growth factor receptor signalling by ligand sequestration. Nature 430, 1040-1044 (2004).